Fox Rothschild LLP partner, William Maruca, was recently interviewed for an article in Cosmos regarding the regulatory risks to hospitals and DME suppliers who enter into arrangements to ensure that COVID-19 patients receive free home oxygen equipment. Some hospitals have decided to take on the inherent risks in such an arrangement to address a
Diagnostic Imaging Services Must Follow Patient Reporting Obligations Under New PA Law
Pennsylvania’s Patient Test Result Information Act, which is set to take effect December 23, 2018, requires diagnostic imaging services providers that identify a “significant abnormality” in their test results to directly notify the patient or his/her designee within 20 days of the completed test, its review and its delivery to the ordering health care practitioner.
Regulatory changes allow patients greater access to medical marijuana in New York state
The New York State Department of Health recently announced two regulatory enhancements to improve patient access to medical marijuana.
On March 22, 2017, chronic pain was added as a new qualifying condition for patients seeking medical marijuana in New York. “Chronic pain” is defined as “any severe debilitating pain that the practitioner determines degrades
Physician Investment in Grower-Processors and Dispensaries of Medical Marijuana in Pennsylvania
Until March 20, 2017, the Pennsylvania Department of Health (the “DOH”) will be accepting applications from companies seeking permits as Grower/Processors and/or Dispensaries of medical marijuana in Pennsylvania. Among other things, these applications require that the applicant raise substantial funding. To do so, certain applicants have been seeking investment from physicians. If you receive such
Pennsylvania Department of Health Clarifies Clinical Laboratory Law
On December 18, 2013, Pennsylvania Act 122 amended the Pennsylvania Clinical Laboratory Act to, among other things, impose licensure requirements on out of state clinical laboratories and to place certain prohibitions on physician financial arrangements with labs. Among other things, Act 122 prohibits the payment or receipt of commissions, bonuses, kickbacks or fee-splitting arrangements and
Does Your Group Practice Income Division Formula Comply with Stark
Many physicians I speak with are still surprised to learn that the federal Stark statute imposes restrictions on income division within group practices. These restrictions only apply to profits generated from any of the Stark “designated health services” and only those that are covered by Medicare and Medicaid (including managed care), but if your group
Do Your Due Diligence – or Get Denied (by NJ Medicaid)
What providers and pharmacists don’t know about their employees can hurt them. That’s the hard lesson learned by a New Jersey pharmacy that had no reason to think the pharmacy it purchased came with an experienced, licensed pharmacist employee with an unsuspected criminal background. Providers should know that falsifying documents, records
New Jersey Surgical Practice Licensure Bill Moves Closer To Becoming Law
New Jersey health care facility licensure bill would require one-room surgical practices to obtain state licensure.
Continue Reading New Jersey Surgical Practice Licensure Bill Moves Closer To Becoming Law
Pennsylvania Adds 19 New Outpatient Surgery Centers
Pennsylvania Adds 19 New Outpatient Surgery Centers
Continue Reading Pennsylvania Adds 19 New Outpatient Surgery Centers
The Race to Complete Physician-Owned Hospitals Is On
For physicians in the process of developing physician-owned hospitals, the race is on to get those facilities up and running by December, 2010. The recently enacted “Health Care and Education Affordability Reconciliation Act of 2010” amends the Stark law to once and for all prohibit physician-owned specialty hospitals unless: (1) the hospital has a